Ordinary Soap Found as Effective as Antibacterial Soap
By HospiMedica staff writers Posted on 04 Sep 2007 |
A new study has found that not only may antibacterial soap make antibiotics less effective, but that is no more useful than ordinary soap.
Researchers at the University of Michigan (U-M; Ann Arbor, USA) carried out a comprehensive analysis of 27 studies conducted between 1980 and 2006, and found that soaps containing triclosan within the range of concentrations commonly used in the community setting (0.1-0.45% wt/vol), was no more effective in preventing infectious illness than plain soap. Moreover, antibacterial soaps at formulations sold to the public do not remove any more bacteria from the hands during washing than plain soaps. Triclosan is used in higher concentrations in hospitals and other clinical settings, and may be more effective at reducing illness and bacteria at these locations.
Because of the way the main active ingredient in many antibacterial soaps (triclosan) reacts in the cells, it may cause some bacteria to become resistant to commonly used drugs such as amoxicillin, according to the researchers. These changes have not been detected at the population level, but Escherichia coli bacteria adapted in lab experiments showed resistance when exposed to as much as 0.1% wt/vol triclosan soap. The study was published in the August 2007 issue of the journal Clinical Infectious Diseases.
"What we are saying is that these E. coli could survive in the concentrations that we use in our [consumer formulated] antibacterial soaps,” said lead author Allison Aiello, Ph.D., M.Sc., an assistant professor of epidemiology at the U-M school of public health. "What it means for consumers is that we need to be aware of what's in the products. The soaps containing triclosan used in the community setting are no more effective than plain soap at preventing infectious illness symptoms, as well as reducing bacteria on the hands.”
Triclosan is a chlorinated aromatic compound that has functional groups representative of both ethers and phenols, and works mainly by inhibiting fatty acid synthesis. Because of the way triclosan kills the bacteria, mutations can happen at the targeted site.
Related Links:
University of Michigan
Researchers at the University of Michigan (U-M; Ann Arbor, USA) carried out a comprehensive analysis of 27 studies conducted between 1980 and 2006, and found that soaps containing triclosan within the range of concentrations commonly used in the community setting (0.1-0.45% wt/vol), was no more effective in preventing infectious illness than plain soap. Moreover, antibacterial soaps at formulations sold to the public do not remove any more bacteria from the hands during washing than plain soaps. Triclosan is used in higher concentrations in hospitals and other clinical settings, and may be more effective at reducing illness and bacteria at these locations.
Because of the way the main active ingredient in many antibacterial soaps (triclosan) reacts in the cells, it may cause some bacteria to become resistant to commonly used drugs such as amoxicillin, according to the researchers. These changes have not been detected at the population level, but Escherichia coli bacteria adapted in lab experiments showed resistance when exposed to as much as 0.1% wt/vol triclosan soap. The study was published in the August 2007 issue of the journal Clinical Infectious Diseases.
"What we are saying is that these E. coli could survive in the concentrations that we use in our [consumer formulated] antibacterial soaps,” said lead author Allison Aiello, Ph.D., M.Sc., an assistant professor of epidemiology at the U-M school of public health. "What it means for consumers is that we need to be aware of what's in the products. The soaps containing triclosan used in the community setting are no more effective than plain soap at preventing infectious illness symptoms, as well as reducing bacteria on the hands.”
Triclosan is a chlorinated aromatic compound that has functional groups representative of both ethers and phenols, and works mainly by inhibiting fatty acid synthesis. Because of the way triclosan kills the bacteria, mutations can happen at the targeted site.
Related Links:
University of Michigan
Latest Patient Care News
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read moreSurgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more